ALB and neoplasm: Clinical imaging to quantify tumor vascularization and permeability is available (50), and clinical albumin imaging agents (58–61) may identify lesions with heterogeneous albumin extravasation (60, 62) to guide treatment with highly protein-bound drugs (63).